Liquid Dosage

Oncology

As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.

Pharmaceutical Development

GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.

In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.

GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.  

Downloads

GEA Insights

Human hands brought together to form a circle

In for the better: Community engagement at GEA

To support community engagement, GEA offers employees one day of paid time off per year.

How a digital rotary parlor supports sustainable dairy farming

How do you lead a dairy farm into the next generation while ensuring a sustainable future and animal welfare while managing increasing complexity? This is a question almost every dairy farmer around the world must consider. The...

GEA misison 30 logo

A strategy for the better: CEO interview on GEA's Mission 30

After reaching its Mission 26 targets two years early, GEA launches Mission 2030 strategy with focus on growth, value and making a positive impact.

Recibir noticias de GEA

Mantente al día de las innovaciones e historias de GEA suscribiéndote a las noticias GEA.

Contacte con nosotros

¡Estamos aquí para ayudar! Con solo un poco de información podremos responder tu consulta.